Organization: FedDev Ontario

The Short Report – May 19, 2021: Ottawa injects $200 million into domestic vaccine manufacturing capacity, CAN Health Network project extended, nuclear leaders prepare CANDU reactors for decommissioning, and more

Resilience Biotechnologies receives significant funding to produce made-in-Canada vaccines, Ottawa extends the CAN Health Network project in Ontario by one year with a $3.25-million investment, Canada’s nuclear leaders collaborate on the decommissioning process, and more.

The Short Report – March 31, 2021: Canadian government invests $925 million in biomanufacturing, funding for variants research, a new digitalization centre, and more

Ottawa announces major funding to expand Sanofi Pasteur’s Ontario facility for domestic biomanufacturing and vaccine preparedness; there’s new funding support for COVID-19 variants research and a new national network, and Siemens launches its first centre to accelerate the digitalization of energy and infrastructure in Canada.